HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.

Bazinet M, Anderson M, Pântea V, Placinta G, Moscalu I, Cebotarescu V, Cojuhari L, Jimbei P, Iarovoi L, Smesnoi V, Musteata T, Jucov A, Dittmer U, Gersch J, Holzmayer V, Kuhns M, Cloherty G, Vaillant A

Open source

DOI
10.1002/hep4.1951
Published
2022 Aug
Container
Hepatology communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/hep4.1951,
  title = {HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.},
  author = {Bazinet M and Anderson M and Pântea V and Placinta G and Moscalu I and Cebotarescu V and Cojuhari L and Jimbei P and Iarovoi L and Smesnoi V and Musteata T and Jucov A and Dittmer U and Gersch J and Holzmayer V and Kuhns M and Cloherty G and Vaillant A},
  year = {2022},
  journal = {Hepatology communications},
  doi = {10.1002/hep4.1951},
  url = {https://doi.org/10.1002/hep4.1951}
}

RIS

TY  - JOUR
TI  - HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
AU  - Bazinet M
AU  - Anderson M
AU  - Pântea V
AU  - Placinta G
AU  - Moscalu I
AU  - Cebotarescu V
AU  - Cojuhari L
AU  - Jimbei P
AU  - Iarovoi L
AU  - Smesnoi V
AU  - Musteata T
AU  - Jucov A
AU  - Dittmer U
AU  - Gersch J
AU  - Holzmayer V
AU  - Kuhns M
AU  - Cloherty G
AU  - Vaillant A
PY  - 2022
JO  - Hepatology communications
DO  - 10.1002/hep4.1951
UR  - https://doi.org/10.1002/hep4.1951
ER  - 

APA

M, B., M, A., V, P., G, P., I, M., V, C., L, C., P, J., L, I., V, S., T, M., A, J., U, D., J, G., V, H., M, K., G, C., & A, V. (2022). HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.. Hepatology communications. https://doi.org/10.1002/hep4.1951

Source records